TW202132557A - 包含海藻醣之血球系列細胞保存用液 - Google Patents

包含海藻醣之血球系列細胞保存用液 Download PDF

Info

Publication number
TW202132557A
TW202132557A TW110101595A TW110101595A TW202132557A TW 202132557 A TW202132557 A TW 202132557A TW 110101595 A TW110101595 A TW 110101595A TW 110101595 A TW110101595 A TW 110101595A TW 202132557 A TW202132557 A TW 202132557A
Authority
TW
Taiwan
Prior art keywords
cells
cell
liquid
trehalose
blood cell
Prior art date
Application number
TW110101595A
Other languages
English (en)
Chinese (zh)
Inventor
白川智景
西村益浩
Original Assignee
日商大塚製藥工場股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商大塚製藥工場股份有限公司 filed Critical 日商大塚製藥工場股份有限公司
Publication of TW202132557A publication Critical patent/TW202132557A/zh

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/46Cellular immunotherapy
    • A61K39/461Cellular immunotherapy characterised by the cell type used
    • A61K39/4611T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/46Cellular immunotherapy
    • A61K39/464Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643Vertebrate antigens
    • A61K39/4644Cancer antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Hematology (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Molecular Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
TW110101595A 2020-01-17 2021-01-15 包含海藻醣之血球系列細胞保存用液 TW202132557A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020-006078 2020-01-17
JP2020006078 2020-01-17

Publications (1)

Publication Number Publication Date
TW202132557A true TW202132557A (zh) 2021-09-01

Family

ID=76863953

Family Applications (1)

Application Number Title Priority Date Filing Date
TW110101595A TW202132557A (zh) 2020-01-17 2021-01-15 包含海藻醣之血球系列細胞保存用液

Country Status (3)

Country Link
JP (1) JP7079045B2 (fr)
TW (1) TW202132557A (fr)
WO (1) WO2021145364A1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4947948B2 (ja) * 2004-10-12 2012-06-06 ニプロ株式会社 細胞保存液
JP5341059B2 (ja) * 2010-11-09 2013-11-13 株式会社大塚製薬工場 幹細胞懸濁液
BR112015030374A2 (pt) * 2013-06-28 2017-07-25 Otsuka Pharma Factory Inc solução contendo trealose e dextrana para transplante de células mamíferas
SG11202111764RA (en) * 2019-04-26 2021-11-29 Otsuka Pharma Factory Inc Trehalose-containing liquid for mammalian cell preservation

Also Published As

Publication number Publication date
JPWO2021145364A1 (fr) 2021-07-22
JP7079045B2 (ja) 2022-06-01
WO2021145364A1 (fr) 2021-07-22

Similar Documents

Publication Publication Date Title
JP5998265B2 (ja) トレハロース及びデキストラン含有哺乳動物細胞移植用溶液
WO2018084228A1 (fr) Solution pour cryoconservation, produit de cryogénisation, et procédé de cryoconservation de cellules animales ou tissus animaux
JP6561173B2 (ja) 哺乳動物細胞投与用液
JP6531256B2 (ja) 臍帯血および末梢血の凍結保存方法および凍結保存用溶液
WO2020189538A1 (fr) Liquide de stockage pour cellules de mammifère
TWI732298B (zh) 包含阿卡波糖或水蘇糖之哺乳動物細胞保存用液
CN113424820A (zh) 一种无血清、无蛋白和无dmso的细胞冻存液及其应用
TW202132557A (zh) 包含海藻醣之血球系列細胞保存用液
JP6830294B1 (ja) トレハロースを含む哺乳動物細胞保存用液
TW202315937A (zh) 細胞之處理方法
CA3063674A1 (fr) Selection et utilisation de fractions de cellules de cordon ombilical appropriees pour une transplantation
WO2021193606A1 (fr) Solution de conservation de cellules de mammifère contenant de l'acarbose et du dextrane
WO2022210574A1 (fr) Agent de traitement de la dystrophie musculaire
WO2018123627A1 (fr) Composition pharmaceutique de cellules, kit pour traitement de maladie, et solution pour suspension de cellules